PedAM
Pediatric Disease Annotations & Medicines
| Disease | encephalopathy |
| Phenotype | C0020541|portal hypertension |
| Sentences | 6 |
| PubMedID- 23133760 | Type c he describes encephalopathy associated with cirrhosis and portal hypertension or portal-systemic shunts. |
| PubMedID- 26203291 | In this review, we address four major areas of cirrhosis management: outpatient management of portal hypertension with decompensation, hepatic encephalopathy, hepatorenal syndrome, and bleeding/coagulation issues. |
| PubMedID- 20482828 | Therefore, we suggest that patients with liver cirrhosis and portal hypertension are at risk of developing clinically relevant encephalopathy when angiotensin-converting enzyme inhibitor and angiotensin ii receptor blocker combination therapy is administered, thus indicating the need for a careful clinical follow-up. |
| PubMedID- 23875049 | When first seen at the clinic all patients had hepatosplenomegaly and portal hypertension, but without ascites, jaundice, encephalopathy and/or pulmonary hypertension, and a history of contact with river water within municipalities located in “zona da mata”, an endemic area for schistosomiasis in pernambuco state. |
| PubMedID- 25141228 | Clues for minimal hepatic encephalopathy in children with noncirrhotic portal hypertension. |
| PubMedID- 23454902 | Cirrhosis results from repeated hepatocellular injury over time, leading to portal hypertension and the development of ascites, hepatic encephalopathy, and varices. |
Page: 1